SPY303.53+4.45 1.49%
DIA255.77+5.52 2.21%
IXIC9,412.36+72.14 0.77%

SVB Leerink Maintains Outperform on Health Catalyst, Raises Price Target to $32

SVB Leerink maintains Health Catalyst (NASDAQ:HCAT) with a Outperform and raises the price target from $31 to $32.

Benzinga · 05/13/2020 11:38

SVB Leerink maintains Health Catalyst (NASDAQ:HCAT) with a Outperform and raises the price target from $31 to $32.